June 20, 1994 |
Andy James' right forearm bulges as he lifts and carries the ladder at the Schuylkill Center for Environmental Education, his T-shirt and jeans are soaked with sweat, and his skin, polished to a shine, shows off the muscle definition. But when confronted by leaves lying on the ground, he shrinks. He asks Eddie Williams, twice his age and no glistening forearm muscles, to take command and lead the charge. "He's one of the people that just don't get it," said James, 31, shaking his head at Williams' immunity.
November 19, 2015 |
When it comes to a still-mysterious condition known as Castleman disease, David Fajgenbaum, a professor of hematology/oncology at the University of Pennsylvania's Perelman School of Medicine, is more than an advocate or a physician/scientist: He is also a patient. Addressing a team of volunteers for the Castleman Disease Collaborative Network (CDCN), Fajgenbaum quickly details on a white board what is known about CD, a group of poorly understood inflammatory disorders that can vary from a single enlarged lymph node to life-threatening multiple organ failure.
June 23, 1989 |
BABY WALKERS. Parents, putting your tots in baby walkers may retard rather than aid their walking. "Recent studies have shown that walker use does not teach babies to walk earlier," the California Medical Association reports. "In fact, there is increasing evidence that the use of walkers delays or changes the way in which a baby learns to walk. " Since 1980, walkers have been involved in nearly 24,000 injuries serious enough to require treatment. Most accidents take place around stairways and stoves, leading the doctors to warn that babies in walkers should never be left alone.
December 31, 2011
Robert Ader, 79, an experimental psychologist who was among the first scientists to show how mental processes influence the body's immune system, a finding that changed modern medicine, died Dec. 20 in Pittsford, N.Y. His death followed a long illness and complications of a fracture suffered in a fall, his daughter Deborah Ader said. Dr. Ader, who spent his entire career as a professor of psychiatry and psychology at the University of Rochester School of Medicine and Dentistry, conducted some of the original experiments in a field he named himself, psychoneuroimmunology.
October 22, 2012
In a sign of how far the science of cancer genomics has come, the University of Pennsylvania Health System will do genetic tests later this year on cancer cells of all patients with several types of cancer. Penn will test up to 48 genes in patients with melanoma, acute myelogenous leukemia, and brain and lung cancer, said Chi V. Dang, director of the Abramson Cancer Center. The results will reveal which patients could benefit from new drugs that work only for those with certain mutations.
October 4, 2011 |
STOCKHOLM - A pioneering researcher was awarded the Nobel Prize in medicine yesterday, three days after dying of pancreatic cancer without ever knowing he was about to be honored for his immune-system work that he had used to prolong his own life. The Nobel committee said it was unaware that Canadian-born cell biologist Ralph Steinman had died when it awarded the prize to him, American Bruce Beutler and French scientist Jules Hoffmann. Since the committee is supposed to consider only living scientists, the Nobel Foundation held an emergency meeting yesterday and said the decision on the 10 million kronor ($1.5 million)
August 23, 2012 |
RESEARCHERS have identified a mysterious new disease that has left scores of people in Asia and some in the United States with AIDS-like symptoms even though they are not infected with HIV. The patients' immune systems become damaged, leaving them unable to fend off germs, as healthy people do. What triggers this isn't known, but the disease does not seem to be contagious. This is another kind of acquired immune deficiency that is not inherited and occurs in adults, but doesn't spread the way AIDS does through a virus, said Dr. Sarah Browne, a scientist at the National Institute of Allergy and Infectious Diseases.
August 11, 1990 |
Major new clinical trials have been approved for a controversial drug that proponents say may prolong indefinitely the lives of patients infected with HIV, the virus that leads to AIDS, Food and Drug Administration officials said yesterday. The trials for Ampligen, an anti-viral compound, will begin next month and involve a total of 135 patients in as many as eight cities, including Philadelphia, according to officials of HEM Research Inc., the Center City firm whose chief scientist, William A. Carter, is a co-inventor of the drug.
October 10, 1989 |
Two pints of bone marrow from a California donor whose tissue is genetically similar to that of a Bucks County leukemia victim at Hahnemann University Hospital were flown here and given to the woman last night in a last-resort attempt to cure her disease. The patient, Deborah Kelly of Levittown, beat 20,000-1 odds when her doctors located an unidentified donor in San Francisco whose bone marrow is genetically similar, according to physicians. That genetic similarity is so statistically rare that it has never happened in the 13-year history of bone-marrow transplantation therapy in this area, Hahnemann doctors said.